logo

GTBP

GT Biopharma·NASDAQ
--
--(--)
--
--(--)

GTBP fundamentals

GT Biopharma (GTBP) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.55 (YoY +74.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.55
+74.65%
Report date
Aug 14, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

GT Biopharma (GTBP) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

GT Biopharma (GTBP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

GT Biopharma (GTBP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

GT Biopharma (GTBP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does GT Biopharma (GTBP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track GT Biopharma (GTBP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield